PharmaCyte Biotech Inc

PharmaCyte Biotech Inc a biotechnology company focuses on developing and commercializing cellular therapies for cancer diabetes and malignant ascites in the United States Its cellular therapies are developed based on CellinaBox a proprietary cellulosebased live cell encapsulation technology used as a platform to treat various types of cancer including advanced and inoperable pancreatic cancer as well as diabetes The company is developing therapies for pancreatic and other solid cancerous tumors a therapy for Type 1 diabetes and insulindependent Type 2 diabetes which include encapsulated genetically modified insulinproducing cells and therapies for cancer based on the constituents of the cannabis plant It has a research agreement with the University of Technology Sydney to create a version of melligen cells to treat diabetes and the University of Northern Colorado to develop methods for the identification separation and quantification of constituents of cannabis The company was formerly known as Nuvilex Inc and changed its name to PharmaCyte Biotech Inc in January 2015 PharmaCyte Biotech Inc was incorporated in 1996 and is headquartered in Las Vegas Nevada